These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8642993)

  • 1. Mycophenolate mofetil to rescue children with acute renal transplant rejection.
    Birkeland SA
    Lancet; 1996 Jun; 347(9016):1699-700. PubMed ID: 8642993
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil for the transplanted kidney?
    Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
    Deierhoi MH; Sollinger HW; Diethelm AG; Belzer FO; Kauffman RS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):693-4. PubMed ID: 8438440
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.
    Davin JC; Gruppen M; Bouts AH; Groothoff JW; van Amstel SP; Surachno J; ten Berge IJ; Weening JJ
    Nephrol Dial Transplant; 1999 Apr; 14(4):984-7. PubMed ID: 10328487
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
    Kiehl MG
    Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil for prevention of acute rejection.
    Winearls CG
    Lancet; 1995 Jul; 346(8969):253-4. PubMed ID: 7616828
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration.
    Filler G; Ehrich J
    Nephrol Dial Transplant; 1997 Feb; 12(2):374-5. PubMed ID: 9132677
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic formulation of mycophenolate mofetil (Myfenax) in de novo renal transplant recipients: results of 12-month observation.
    Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A
    Transplant Proc; 2014 Oct; 46(8):2683-8. PubMed ID: 25380894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolving role of mycophenolate mofetil in renal transplantation.
    Warrens AN
    QJM; 2000 Jan; 93(1):15-20. PubMed ID: 10623777
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe acute vascular rejection in a renal allograft with mycophenolate mofetil and high dose steroids.
    Lafferty ME; Lang S; McGregor E; Henderson IS; Jones MC
    Scott Med J; 1997 Jun; 42(3):79-80. PubMed ID: 9351121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate Mofetil Study.
    Baltzan M; Shoker A; Baltzan R
    Transplantation; 1997 Jan; 63(1):173-4. PubMed ID: 9000687
    [No Abstract]   [Full Text] [Related]  

  • 15. Is mycophenolate mofetil better than azathioprine in organ transplantation?
    Ruggenenti P; Remuzzi G
    Transplantation; 2006 Nov; 82(9):1242-3. PubMed ID: 17102781
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetil.
    Hazzan M; Provot F; Glowacki F; Copin MC; Roumilhac D; Labalette M; Pruvot FR; Noel C
    Transpl Int; 2004 Oct; 17(9):525-30. PubMed ID: 15338120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.
    Höcker B; Weber LT; Bunchman T; Rashford M; Tönshoff B;
    Pediatr Transplant; 2005 Aug; 9(4):504-11. PubMed ID: 16048604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
    Rerolle JP; Szelag JC; Le Meur Y
    Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.